DalsnaFinance

Epigenetic Clocks vs. VO₂ Max: How Do You Actually Prove a Longevity Treatment Is Working? Healthi Life Analysis Explores Which Biomarkers Hold Up Under Placebo-Controlled Scrutiny

Markets PR Newswire By PR Newswire 25 Jun 2026 18:00 1 min read
Epigenetic Clocks vs. VO₂ Max: How Do You Actually Prove a Longevity Treatment Is Working? Healthi Life Analysis Explores Which Biomarkers Hold Up Under Placebo-Controlled Scrutiny

Epigenetic clocks can detect a 4.9-year shift in PhenoAge under double-blind conditions, while VO₂ max — one of the strongest longevity predictors known — stays flat; the measurement you choose may decide whether a treatment looks like a breakthrough or a placebo. — Corley et al.,...

Epigenetic clocks can detect a 4.9-year shift in PhenoAge under double-blind conditions, while VO₂ max — one of the strongest longevity predictors known — stays flat; the measurement you choose may decide whether a treatment looks like a breakthrough or a placebo. — Corley et al.,...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.